Advancing cooperation on health technology assessment (HTA) and supporting the implementation of the new EU legal framework on HTA
Deliverable D5.3.1 on selection criteria for JCA assessor and co-assessor is now published.
EUnetHTA 21 is pleased to announce the publication of the deliverable D5.3.1 on selection criteria for JCA assessor and co-assessor. More information can be found
Public Consultation for D4.7.3 and D4.7.4 is now open
EUnetHTA 21 announces that the public consultation for D4.7.3/D4.7.4 (EUDAMED data reporting template / Guidance for EUDAMED-based TISP process) is open until 05.07.2022, 23:59 CET.
EUnetHTA 21 launches 2nd Open Call for parallel EMA/EUnetHTA 21 Joint Scientific Consultations (JSCs)
EUnetHTA 21 launches the second Open Call for applications from the pharmaceutical industry for five Joint Scientific Consultations (JSCs). The Open Call will remain open
EUnetHTA 21 announces public consultation for three deliverables
EUnetHTA 21 announces that the public consultation for D4.2 (scoping process), D4.3.2 (guideline for comparators and comparisons) and D4.7.1/4.7.2 (framework for assessment of high-risk MD) is
D5.3.2 HTAb Technical Expert Working Group is open for public consultation until March 20 2022, 23:59 CET.
EUnetHTA 21 announces that the public consultation for D5.3.2 – HTAb technical expert working groups is open until 20-05-2022, 23:59 CET. The draft deliverable as well as the
EMA and the EUnetHTA 21 consortium set priorities for their collaboration
The EUnetHTA 21 Consortium is pleased to announce that the EUnetHTA 21-EMA Work Plan is now publicly available. We would like to thank everyone who
Joint HTA Work
EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional, and European levels. These include Joint Scientific Consultations, Parallel Consultations, and Post Launch Evidence Generation (PLEG). Find out more here.
Tools
EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint work process, helping partners to proceed with a defined methodology. Access all current and archived tools here.
COVID-19 Response
EUnetHTA has prioritised COVID-19-related initiatives above other work during the current time. Here you will find updated information and publications relating to COVID-19 diagnostic testing, therapeutic treatments, and useful links to further data from our network partners.
Get Involved
EUnetHTA functions as a collaboration between network members and exterior partners to develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out more about partner involvement, activities, and EUnetHTA events here.
